How is the Arcutis Biotherapeutics Inc today?

The Arcutis Biotherapeutics Inc today is trading in the down by -4.58% at 13.74.

How has Arcutis Biotherapeutics Inc performed historically?

The Arcutis Biotherapeutics Inc is currently trading down -4.58% on an intraday basis in the past week the index rose 0.51%. The index has been down -16.58% in the past quarter and rose 47.90% in the past year. You can view this in the overview section.

What is Arcutis Biotherapeutics Inc Annual Revenue?

Arcutis Biotherapeutics Inc Annual Revenue rose 229.74%, in the last year to $196.54 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Arcutis Biotherapeutics Inc Annual Net Profit?

Arcutis Biotherapeutics Inc Annual Net Profit rose 46.58% in the last year to $140.04 M. Its sector's average net profit growth for the last fiscal year was -14.06%.

What is Arcutis Biotherapeutics Inc Price to Earning Ratio?

Arcutis Biotherapeutics Inc Price to Earning Ratio is -12.63, which is negative.

What is Arcutis Biotherapeutics Inc Stock Price?

Arcutis Biotherapeutics Inc Stock Price rose 47.9% and outperformed its sector by 13.03% in the past year.

What is Arcutis Biotherapeutics Inc Quarterly Revenue?

Arcutis Biotherapeutics Inc Quarterly Revenue rose 32.84% YoY to $65.85 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Arcutis Biotherapeutics Inc Quarterly Net profit?

Arcutis Biotherapeutics Inc Quarterly Net profit rose 29.17% YoY to $25.06 M. Its sector's average net profit growth YoY for the quarter was -235.94%.

What is Arcutis Biotherapeutics Inc Debt to Equity Ratio?

Arcutis Biotherapeutics Inc Debt to Equity Ratio of 0.7 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Arcutis Biotherapeutics Inc Return on Equity(ROE)?

Arcutis Biotherapeutics Inc Return on Equity(ROE) for the last financial year was -113.76%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Arcutis Biotherapeutics Inc Mutual Fund Holding?

Arcutis Biotherapeutics Inc Mutual Fund Holding decreased by 0.81% in the last quarter to 54.66.

What is Arcutis Biotherapeutics Inc Promoter Share Holding?

Arcutis Biotherapeutics Inc Promoter Share Holding decreased by 0.34% in the most recent quarter to 6.85%.

What is Arcutis Biotherapeutics Inc Interest Coverage Ratio?

Arcutis Biotherapeutics Inc Interest Coverage Ratio is -4.13, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Arcutis Biotherapeutics Inc Institutional Holding?

Arcutis Biotherapeutics Inc Institutional Holding remained the same in the last quarter at 98.71%.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
ARCUTIS BIOTHERAPEUTICS INC

Arcutis Biotherapeutics Inc XNAS: ARQT

Arcutis Biotherapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Arcutis Biotherapeutics Inc: Is Infosys Ltd. worth buying?
Item: Arcutis Biotherapeutics Inc
Rating: 1.695541625
Author: Trendlyne DVM scores

Momentum Trap

about

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentia...

13.74 -0.66 (-4.58%)

74.81% Gain from 52W Low

2.3M

XNAS Volume

XNAS 27 Jun, 2025 5:30 PM (EDT)

Low Financial Strength

33.3 / 100

Expensive Valuation

9.2 / 100

Technically Neutral

59.8 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 54%

7 analysts

Arcutis Biotherapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Arcutis Biotherapeutics Inc Live Share Price Today, Share Analysis and Chart

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentia...

74.81% Gain from 52W Low

SWOT Analysis

Arcutis Biotherapeutics Inc Live Price Chart

Arcutis Biotherapeutics Inc FAQ

How is Arcutis Biotherapeutics Inc today?

Arcutis Biotherapeutics Inc today is trading in the red, and is down by -4.58% at 13.74.

How has Arcutis Biotherapeutics Inc performed historically?

Arcutis Biotherapeutics Inc is currently trading down -4.58% on an intraday basis. In the past week the stock rose 0.51%. stock has been down -16.58% in the past quarter and rose 47.90% in the past year. You can view this in the overview section.